MedPath

Walking With the SAIRE Smart Walker

Not Applicable
Completed
Conditions
Walking, Difficulty
Gait Disorders, Neurologic
Gait Disorders in Old Age
Interventions
Device: Standard 4-wheeled walker
Other: No walking aid
Device: SAIRE smart walker
Registration Number
NCT05461677
Lead Sponsor
Vrije Universiteit Brussel
Brief Summary

The current study aims to investigate the effect of walking with the SAIRE smart walker on spatiotemporal parameters and gait kinematics in a population who suffer from difficulties during gait, and compare this to walking with a standard walker or no walking aid.

Detailed Description

This study is an experimental single group study investigating the effect of walking with a smart walker compared to walking with a standard walker or no walking aid in persons who suffer from gait difficulties. Participants will perform one session of walking in three different conditions, (1) walking with the SAIRE smart walker, (2) walking with a standard walker and (3) if the participants are able to walk without the use of an assistive device, walking without a walker. During this session, gait parameters will be compared between the three conditions.

Experimental session: During the experimental session, participants will walk along the 10-meter walkway (5 times for every condition) After every 5 trials, a rest period of minimum 5 minutes will be held to avoid fatigue. Three different walking conditions will be measured: (1) walking with the SAIRE smart walker, (2) walking with a standard walker and if possible (3) walking with no walking aid. Each walking condition will be measured five consecutive times in a randomized order. The order of the conditions will be randomized using closed envelopes containing notes that say what order of conditions will be used. This randomization is done to avoid fatigue effects that might occur when a strict order is used.

Before the start of the experimental session, participants will practice using the SAIRE smart walker for maximum 10 minutes to familiarize with the feedback given by the walker. After this familiarization session, the surface electrodes and reflective markers will be placed on the participants and the experimental session will start.

Analysis: This study will investigate the difference in gait biomechanics of adults with gait difficulties while using different walking aids.

Descriptive statistics of the baseline characteristics of all participants will be performed. The effect of gait with a smart walker on spatiotemporal gait parameters, kinematics and muscle activity will be compared to gait with a standard 2-wheeled walker and gait without a walking aid. Data will be visualized using LO(W)ESS smoothing (locally weighted scatterplot smoothing) to explore the effect (per condition and outcome). Values will be compared between conditions in a one-way repeated measures analysis of variance. For the analysis of the USE questionnaire, percentage distribution of every item and mean scores for every subscale will be calculated using Microsoft Excel (Microsoft, Washington, DC).

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
14
Inclusion Criteria
  • Ability to walk along a 10-meter walkway multiple times over a period of 120 minutes
  • Ambulation with any sort of assistive device (e.g. cane, crutches, walker, etc.)
  • Sufficient arm/hand function to walk with a walker
  • Capable of understanding and carrying out instructions
  • Capable of giving informed consent
Exclusion Criteria
  • Presence of cognitive impairement (MoCA score <23)

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Standard walkerStandard 4-wheeled walkerThe comparator device consist of a standard 4-wheeled walker
No walking aidNo walking aid-
SAIRE smart walkerSAIRE smart walkerThe investigational device used in this clinical investigation is called the SAIRE smart walker. This first prototype version is equipped with a depth camera and two cheaper cameras. The depth camera is used to acquire high-quality data to train artificial intelligence (AI) models which then can run on the cheaper camera modules. Additionally, two ultrasonic sensors are applied to estimate the distance. A touch monitor is used to provide audiovisual feedback and display the user interface. Two LED strips are also attached to the walker to provide additional visual feedback to the patient. The SAIRE smart walker gives feedback to the patient in terms of cadence using a metronome, and foot placement using the LED strips and the video stream presented on the monitor. Additionally, the walker will give information about step length and step width through AI-models.
Primary Outcome Measures
NameTimeMethod
3D kinematic measurements of the lower limbAt the end of the experimental session, Day 1

Kinematic data (i.e., movement amplitudes of the bilateral hip, knee and ankle joint) of the lower limbs during walking will be recorded continuously with the use of a 14-camera Vicon Vero 1.3 system at 100 Hz.

Stance timeAt the end of the experimental session, Day 1

Stance time of the lower limbs during walking will be recorded continuously with the use of a 14-camera Vicon Vero 1.3 system at 100 Hz.

Double limb support periodAt the end of the experimental session, Day 1

Double limb support period will be recorded continuously with the use of a 14-camera Vicon Vero 1.3 system at 100 Hz.

ElectromyographyAt the end of the experimental session, Day 1

Muscle activity of the lower limb muscles (bilateral: M. rectus femoris, M. vastus lateralis, M. biceps femoris, M. tibialis anterior, M. gastrocnemius medialis) will be recorded continuously during treadmill walking with the use of surface electrodes. Signals will be recorded with the wireless Cometa Wave Plus EMG system (16 channels).

Step lengthAt the end of the experimental session, Day 1

Step length will be recorded continuously with the use of a 14-camera Vicon Vero 1.3 system at 100 Hz.

Step timeAt the end of the experimental session, Day 1

Step time will be recorded continuously with the use of a 14-camera Vicon Vero 1.3 system at 100 Hz.

Walking speedAt the end of the experimental session, Day 1

Walking speed will be recorded continuously with the use of a 14-camera Vicon Vero 1.3 system at 100 Hz.

Swing time of the lower limbsAt the end of the experimental session, Day 1

Swing time of the lower limbs during walking will be recorded continuously with the use of a 14-camera Vicon Vero 1.3 system at 100 Hz.

CadenceAt the end of the experimental session, Day 1

Cadence will be recorded continuously with the use of a 14-camera Vicon Vero 1.3 system at 100 Hz.

Single limb support periodAt the end of the experimental session, Day 1

Single limb support period will be recorded continuously with the use of a 14-camera Vicon Vero 1.3 system at 100 Hz.

Secondary Outcome Measures
NameTimeMethod
User experience with a modified version of the USE questionnaireAt the end of the experimental session, Day 1

User experience will be assessed using a translated version of the self-administered Usefulness, Satisfaction and Ease of use (USE) questionnaire. This scale ranges from 30 to 210, with a higher score translating to higher satisfaction. Additionally, open questions were added to the questionnaire to uncover possible barriers and facilitators in the use of the smart walker.

Trial Locations

Locations (1)

Brubotics Rehabilitation Research center

🇧🇪

Jette, Brussels Hoofdstedelijk Gewest, Belgium

© Copyright 2025. All Rights Reserved by MedPath